ION BEAM APPLICATIONS (IBAB.BR) Stock Fundamental Analysis
EBR:IBAB - BE0003766806 - Common Stock
11.68 EUR
-0.32 (-2.67%)
Taking everything into account, IBAB scores 4 out of 10 in our fundamental rating. IBAB was compared to 58 industry peers in the Health Care Equipment & Supplies industry. IBAB has a medium profitability rating, but doesn't score so well on its financial health evaluation. IBAB has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year IBAB was profitable.
In the past year IBAB has reported a negative cash flow from operations.
IBAB had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: IBAB reported negative operating cash flow in multiple years.
1.2 Ratios
IBAB's Return On Assets of 1.50% is in line compared to the rest of the industry. IBAB outperforms 43.10% of its industry peers.
IBAB has a better Return On Equity (8.34%) than 65.52% of its industry peers.
The Return On Invested Capital of IBAB (11.77%) is better than 87.93% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IBAB is below the industry average of 8.86%.
The 3 year average ROIC (6.33%) for IBAB is below the current ROIC(11.77%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.5% | ||
| ROE | 8.34% | ||
| ROIC | 11.77% |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.33%
ROIC(5y)6.79%
1.3 Margins
IBAB has a Profit Margin of 1.86%. This is comparable to the rest of the industry: IBAB outperforms 43.10% of its industry peers.
In the last couple of years the Profit Margin of IBAB has declined.
Looking at the Operating Margin, with a value of 5.60%, IBAB is doing worse than 60.34% of the companies in the same industry.
IBAB's Operating Margin has improved in the last couple of years.
IBAB has a Gross Margin of 33.32%. This is in the lower half of the industry: IBAB underperforms 79.31% of its industry peers.
In the last couple of years the Gross Margin of IBAB has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.6% | ||
| PM (TTM) | 1.86% | ||
| GM | 33.32% |
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
2. Health
2.1 Basic Checks
IBAB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, IBAB has more shares outstanding
The number of shares outstanding for IBAB has been reduced compared to 5 years ago.
IBAB has a worse debt/assets ratio than last year.
2.2 Solvency
IBAB has an Altman-Z score of 1.48. This is a bad value and indicates that IBAB is not financially healthy and even has some risk of bankruptcy.
IBAB has a Altman-Z score (1.48) which is comparable to the rest of the industry.
IBAB has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.23, IBAB is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.48 |
ROIC/WACC1.63
WACC7.21%
2.3 Liquidity
A Current Ratio of 0.95 indicates that IBAB may have some problems paying its short term obligations.
IBAB has a worse Current ratio (0.95) than 86.21% of its industry peers.
A Quick Ratio of 0.63 indicates that IBAB may have some problems paying its short term obligations.
IBAB has a worse Quick ratio (0.63) than 84.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.63 |
3. Growth
3.1 Past
IBAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 110.64%, which is quite impressive.
Measured over the past 5 years, IBAB shows a small growth in Earnings Per Share. The EPS has been growing by 3.99% on average per year.
Looking at the last year, IBAB shows a quite strong growth in Revenue. The Revenue has grown by 18.44% in the last year.
IBAB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.01% yearly.
EPS 1Y (TTM)110.64%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%74.97%
Revenue 1Y (TTM)18.44%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.69%
3.2 Future
Based on estimates for the next years, IBAB will show a very strong growth in Earnings Per Share. The EPS will grow by 58.13% on average per year.
The Revenue is expected to grow by 2.63% on average over the next years.
EPS Next Y208.45%
EPS Next 2Y114.61%
EPS Next 3Y71%
EPS Next 5Y58.13%
Revenue Next Year16.35%
Revenue Next 2Y11.01%
Revenue Next 3Y8.55%
Revenue Next 5Y2.63%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
IBAB is valuated rather expensively with a Price/Earnings ratio of 20.49.
IBAB's Price/Earnings ratio is a bit cheaper when compared to the industry. IBAB is cheaper than 79.31% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.44. IBAB is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 10.51, the valuation of IBAB can be described as very reasonable.
91.38% of the companies in the same industry are more expensive than IBAB, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, IBAB is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.49 | ||
| Fwd PE | 10.51 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IBAB is valued cheaper than 87.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.46 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IBAB's earnings are expected to grow with 71.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)5.14
EPS Next 2Y114.61%
EPS Next 3Y71%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.45%, IBAB has a reasonable but not impressive dividend return.
IBAB's Dividend Yield is a higher than the industry average which is at 2.16.
With a Dividend Yield of 1.45, IBAB pays less dividend than the S&P500 average, which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.45% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IBAB pays out 52.84% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP52.84%
EPS Next 2Y114.61%
EPS Next 3Y71%
EBR:IBAB (9/11/2025, 7:00:00 PM)
11.68
-0.32 (-2.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners25.71%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap353.67M
Analysts80
Price Target15.81 (35.36%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.45% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP52.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.72%
PT rev (3m)-2.72%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-20.44%
EPS NY rev (3m)-20.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.49 | ||
| Fwd PE | 10.51 | ||
| P/S | 0.71 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.19 | ||
| P/tB | 4.15 | ||
| EV/EBITDA | 8.46 |
EPS(TTM)0.57
EY4.88%
EPS(NY)1.11
Fwd EY9.52%
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS16.45
BVpS3.66
TBVpS2.82
PEG (NY)0.1
PEG (5Y)5.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.5% | ||
| ROE | 8.34% | ||
| ROCE | 18.95% | ||
| ROIC | 11.77% | ||
| ROICexc | 23.1% | ||
| ROICexgc | 35.13% | ||
| OM | 5.6% | ||
| PM (TTM) | 1.86% | ||
| GM | 33.32% | ||
| FCFM | N/A |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.33%
ROIC(5y)6.79%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.19%
ROCE(5y)10.93%
ROICexcg growth 3YN/A
ROICexcg growth 5Y53.77%
ROICexc growth 3Y-88.07%
ROICexc growth 5Y51.35%
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
F-Score5
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.65 | ||
| Cap/Depr | 63.41% | ||
| Cap/Sales | 1.49% | ||
| Interest Coverage | 20.73 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.63 | ||
| Altman-Z | 1.48 |
F-Score5
WACC7.21%
ROIC/WACC1.63
Cap/Depr(3y)79.57%
Cap/Depr(5y)64.6%
Cap/Sales(3y)2.05%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.64%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%74.97%
EPS Next Y208.45%
EPS Next 2Y114.61%
EPS Next 3Y71%
EPS Next 5Y58.13%
Revenue 1Y (TTM)18.44%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.69%
Revenue Next Year16.35%
Revenue Next 2Y11.01%
Revenue Next 3Y8.55%
Revenue Next 5Y2.63%
EBIT growth 1Y269.56%
EBIT growth 3Y27.16%
EBIT growth 5Y65.71%
EBIT Next Year224.83%
EBIT Next 3Y67.74%
EBIT Next 5Y52.33%
FCF growth 1Y43.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.44%
OCF growth 3YN/A
OCF growth 5YN/A